Are Options Traders Bullish on AKCA?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About AKCA

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, Inc., is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. Akcea is advancing a mature pipeline of four novel drugs, including volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, all with the potential to treat multiple diseases. All four drugs were discovered by and are being co-developed with Ionis, a leader in antisense therapeutics, and are based on Ionis proprietary antisense technology. The most advanced drug in its pipeline, volanesorsen, is under regulatory review in the U.S., EU and Canada for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL. Akcea is building the infrastructure to commercialize its drugs globally with a focus on lipid specialists as the primary call point. Akcea is located in Cambridge, Massachusetts.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AKCA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 283.8 M 2.83842E+08 202 202 0.16% 0.00162258 955 K 954785
EQWS Invesco Russell 2000 Equal Weight ETF 20.8 M 2.08E+07 1,977 1977 0.04% 0.0004 8 K 8275
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 347 347 0.01% 0.00012123 194 K 193731
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.00963E+09 191 191 0.36% 0.0036 29.4 M 2.94361E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.3 B 1.53181E+10 3,420 3420 0.0% 0 421 K 421279
IWM iShares Russell 2000 ETF 44.5 B 4.44813E+10 2,022 2022 0.02% 0.0002 8.7 M 8650310
IWO iShares Russell 2000 Growth ETF 9.0 B 8.98678E+09 1,240 1240 0.04% 0.0004 3.4 M 3432320
IWV iShares Russell 3000 ETF 8.4 B 8.38911E+09 3,006 3006 0.0% 0 135 K 135360
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.02% 0.000236875 438 K 438338
SBIO ALPS Medical Breakthroughs ETF 221.8 M 2.21846E+08 112 112 1.91% 0.0191 4.2 M 4237258
UBIO Proshares UltraPro Nasdaq Biotechnology 28.8 M 2.87594E+07 196 196 0.08% 0.000761646 72 K 72430
URTY ProShares UltraPro Russell2000 108.8 M 1.08826E+08 2,033 2033 0.0% 3.5019E-05 13 K 12872
UWM ProShares Ultra Russell2000 162.8 M 1.62825E+08 2,033 2033 0.01% 7.68848E-05 27 K 26753
XPH SPDR S&P Pharmaceuticals ETF 305.8 M 3.0583E+08 46 46 0.82% 0.0081553 2.5 M 2492387

Wait, Before You Leave...